Fresenius Kabi Glutamine — Dietary Support Amino Acid Powder
Fresenius Kabi Glutamine is a high-dose, clinical-grade formulation designed to assist patients undergoing medical therapy with elevated metabolic demands. L-glutamine is a vital amino acid that serves as a primary energy source for rapidly dividing cells, particularly within the intestinal mucosa and immune system. During periods of clinical stress, mucosal injury, or oncological treatments, endogenous synthesis may be insufficient, making dietary supplementation critical. This neutral-flavoured powder integrates seamlessly into various liquids and pureed foods to support patient nutritional adherence.
Key Features
- High in glutamine (10 g per sachet)
- Convenient single-dose powder sachets for easy use
- Flavour: Neutral
It is recommended to use this product in consultation with your healthcare practitioner.
Recommended Usage
To be determined by a healthcare practitioner according to patients’ needs.
Recommended for supplementary nutrition: Two to three sachets (40 – 60 g equivalent to 20 – 30 g glutamine) per day, ≥ 5 days.
Recommendation for cancer patients to start 3 – 5 days prior to chemo- or radiation therapy and continue for ≥ 5 days thereafter.
Composition
| Serving size: 20 g Sachet | Amount per serving |
| Energy | 74 kcal |
| Protein | 0 g |
| Glutamine | 10 g |
| Fat | 0 g |
| Carbohydrates | 8 g |
| Fibre* | 1.2 g |
*Source: stabiliser (E 414)
Other Ingredients
L-glutamine, starch, maltodextrin, stabiliser (E 414)
Does Not Contain
Gluten or lactose
Kosher and Halal certified
Storage
At room temperature: 15 – 25 °C.
Product Form
Sachet
Warnings & Contraindications
It is recommended to use this product in consultation with your healthcare practitioner.
If pregnant, nursing or taking medication, consult your healthcare practitioner before use.
Not suitable for children < 3 years.
Use with caution in children < 6 years.
Do not use this product if you have an allergy or sensitivity to any of the ingredients.
Please review package insert (if available) for further information.



